BASF INDIA LTD.

BASF India's consolidated PAT fell 42.4% year-on-year to ₹61.7 Cr in Q2 FY27 (vs ₹107.2 Cr in Q2 FY26) even as revenue grew 19.5% YoY to ₹4,832.2 Cr, and was down 82.9% sequentially from ₹360.3 Cr in Q1 FY27 — though that base included an ₹18.2 Cr one-off gain on the BASF India Coatings divestment plus a much stronger operating quarter. Net margin compressed to roughly 1.3% from 7.4% in Q1 FY27 and 2.6% a year ago; operating margin (segment EBIT/revenue) fell to about 2.2% versus ~10.8% last quarter and ~4.0% in the year-ago quarter. EPS was ₹14.3 (not annualised) against ₹80.4 in Q1 FY27 and ₹23.3 in Q2 FY26. The squeeze was concentrated in the commodity-linked segments. Materials (Performance Materials + Monomers) grew revenue 29% YoY to ₹1,464.3 Cr but swung to a ₹0.5 Cr segment loss from a ₹36.4 Cr profit a year ago — the single biggest drag on the consolidated print, consistent with cost/spread pressure since volumes clearly held up. Chemicals (Petrochemicals/Intermediates) also flipped to an ₹8.1 Cr loss from a ₹12.3 Cr profit, and the residual "Others" bucket swung to a ₹6.1 Cr loss. Agricultural Solutions posted a ₹28.6 Cr loss versus a ₹50.1 Cr profit a year ago and ₹77.5 Cr last quarter, but the company itself flags this segment as seasonal, so the swing should be read with that caveat rather than as a standalone red flag. Against this, Nutrition & Care and Industrial Solutions were clear bright spots — segment profit up roughly 604% YoY to ₹65.5 Cr and 80% YoY to ₹83.6 Cr respectively, both outpacing their already-strong revenue growth (+35% and +23% YoY). No broker consensus for this specific quarter turned up in search, so vsStreet is unknown; full-year FY27 consensus pegs revenue growth near 8.8% and EPS growth near 23%, which this quarter's YoY revenue beat but PAT trajectory does not yet support. Management gave no formal guidance last quarter — it explicitly stated it would not forecast future performance — so there is no outlook to grade this print against; the only trackable commitments are structural: continued renewable-power sourcing (BASF added a 14.18% stake in Clean Max Galapagos on Aug 4, 2026, toward its 75-80%-renewable-power target) and the Agri Solutions demerger, which shareholders approved on Jun 24, 2026 and which the company is targeting for an H1 2027 listing, still subject to regulatory approvals. The quarter also saw BASF announce closure of its Dahej Care Chemicals plants by year-end (Aug 4, 2026) even as the Nutrition & Care segment it sits within delivered the quarter's strongest growth, and the company is separately evaluating a new MDI investment at Dahej (Sep 21, 2026) in the same Materials franchise that just posted a loss. Going into Q3 FY27, the readthrough is a profitable but margin-challenged quarter where topline strength in Nutrition & Care and Industrial Solutions was offset by a sharp swing to losses in Materials and Chemicals, with Agri Solutions' loss complicated by known seasonality.

BASF India Ltd has announced that its trading window for dealing in the company's equity shares will be closed from October 1, 2026, to November 9, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will reopen 48 hours after the Board of Directors approves and declares the standalone and consolidated unaudited financial results for the quarter and half-year ending September 30, 2026. The Board meeting to consider these results is scheduled for November 4, 2026.

BASF India Ltd has announced that its Board of Directors will convene on November 4, 2026, to consider and approve the Unaudited Financial Results for the quarter and half-year ending September 30, 2026. The meeting will cover both standalone and consolidated financial statements. The company will disseminate the approved results post-meeting as per SEBI regulations.

BASF SE is evaluating a significant investment in India to establish a new MDI (methylene diphenyl diisocyanate) production complex. The company has secured land in Dahej, Gujarat, through its Indian subsidiary, BASF India Polyurethanes Private Limited. This potential investment aims to meet growing regional customer demand for MDI, a crucial component in polyurethane products used across various industries including construction, automotive, and consumer goods. The final decision is contingent on the completion of a feasibility study and obtaining necessary approvals.

BASF India Limited conducted its 82nd Annual General Meeting on August 12, 2026, via video conferencing. The meeting was presided over by Chairman Mr. Pradip P. Shah. Key management personnel, including the Managing Director, CFO, and various directors, were present. The transcript of the AGM will be hosted on the company's website. The meeting covered procedural aspects for virtual conduct, including shareholder participation and the process for the question-and-answer session. The company confirmed that 73.33% of paid-up equity capital was represented, making the appointment of proxies not applicable. Mr. Alexander Gerding was authorized to conduct the remaining proceedings, including e-voting and declaration of results.

BASF India Limited held its 82nd Annual General Meeting (AGM) on August 12, 2026. The company presented information to its shareholders, emphasizing its strong commitment to Environment, Health, and Safety (EHS). Key highlights included zero high severity incidents (HSI) and process safety incidents (PSI) from April 25 to July 26, with only 2 Lost Time Injuries (LTI) in the same period. The company continues to focus on improving safety leading indicators and nurturing its safety culture through initiatives like mock drills and training. Sites at Thane and Panoli achieved a GREEN rating in Responsible Care (RC) Audits, reinforcing the company's dedication to safety and sustainability.

BASF India's Board of Directors has approved the closure of sulfation & low temperature reactor plants for its Care Chemicals Business at the Dahej manufacturing site. This decision, effective by the end of calendar year 2026, is attributed to a challenging competitive landscape in India, leading to overcapacities, high costs, and margin pressure. The Care Chemicals business will continue to operate and serve customers with other products. In FY 2025-26, the affected Dahej operations contributed ₹542 crore in revenue, representing 4% of the company's total revenue and were part of the Nutrition & Care Segment.

BASF India Limited's Board of Directors has approved the acquisition of a 14.18% stake in Clean Max Galapagos Private Limited for an amount not exceeding INR 9.45 million. This acquisition is for the procurement of approximately 4,240 MWh per year of renewable solar power for its Navi Mumbai manufacturing site, under the Group Captive Power Generation Mechanism. The transaction is subject to the signing of definitive agreements, including a Shareholders' Agreement and a 25-year Power Purchase Agreement, along with other specified conditions. The company has clarified that this is not a related party transaction and does not involve any stake or interest from promoters or their group companies in the acquired entity.

BASF India's Q1 FY27 (quarter ended June 30, 2026) consolidated profit for the period surged to ₹360.29 Cr, up 162.2% year-on-year from ₹137.40 Cr and up 423.1% sequentially from a weak ₹68.88 Cr in Q4 FY26. Stripping out the ₹18.15 Cr exceptional gain booked on the sale of BASF India Coatings, adjusted YoY PAT growth is still ~149.0%, confirming the beat is driven by core operations and not the one-off. Revenue from continuing operations (the statement now excludes the divested Coatings business) came in at ₹4,824.26 Cr, up 24.5% YoY over a base of ₹3,874.54 Cr that still included Coatings, and up 40.1% QoQ. Standalone PAT of ₹362.05 Cr is within 0.5% of the consolidated figure, so both bases tell the same story. The expansion is margin-led: consolidated net margin rose to ~7.5% from 3.5% YoY and 2.0% QoQ, while segment operating margin improved to ~10.8% from 5.5% YoY and 3.2% QoQ. The swing is concentrated in two segments — Materials PBIT flipped from a ₹11.62 Cr loss in Q1 FY26 to a ₹212.69 Cr profit this quarter, and Chemicals PBIT rose to ₹96.12 Cr from ₹16.32 Cr — consistent with a recovery in petrochemical/monomer spreads rather than a volume story. That was partly offset by Agricultural Solutions, whose PBIT fell 53% YoY to ₹77.49 Cr from ₹165.39 Cr, and Nutrition & Care, down to ₹11.06 Cr from ₹20.23 Cr. Agricultural Solutions' QoQ swing (from a ₹19.83 Cr loss to a ₹77.49 Cr profit) is a known seasonal pattern the filing itself flags for that segment, so it should not be read as trend confirmation — the YoY decline is the more telling number. Against our pre-result preview, the print is a clear beat: the preview flagged revenue of ₹3,400-3,600 Cr, OPM of 12-14%, and PBT margin of 3-4% for the quarter — actual revenue of ₹4,824 Cr and PBT margin of ~10% both surpass those markers, though OPM at ~10.8% lands modestly below the previewed band. Q1 FY27 basic EPS of ₹83.3 alone is already ~98% of the ₹85.10 FY27 full-year consensus EPS the preview cited, implying either this run-rate isn't sustainable for the full year or consensus needs a material upward revision. Management's prior concall (May 2026) offered no quantitative guidance, only qualitative priorities — protecting margins, executing the Celesto and Dispersion Line 3 expansions, and completing the Coatings and Agricultural Solutions portfolio actions; margin protection was not just met but exceeded, though no company press release with management's own framing of this quarter could be extracted from this filing. On the portfolio actions: the Coatings stake sale (100%, ₹230.16 Cr consideration) completed June 30, 2026 and is booked as an exceptional item/discontinued operation this quarter; the Agricultural Solutions demerger cleared its shareholders' meeting on June 24, 2026 but remains subject to further regulatory approvals per the filing notes. Separately, the company disclosed a 14.18% stake acquisition in Clean Max Galapagos the same day as this result, a renewable-energy investment not reflected in this quarter's P&L. Going into Q2 FY27, the key monitorables are whether the Materials/Chemicals spread recovery holds, the final terms and timeline of the Agricultural Solutions demerger, and whether full-year consensus estimates get revised given this quarter alone already captured most of the previously flagged FY27 EPS estimate.

BASF India Limited has dispatched inland letters to shareholders whose email addresses are not registered, providing the web link to access the Annual Report for FY 2025-26 and the Notice for the 82nd Annual General Meeting (AGM). The AGM is scheduled for August 12, 2026, via Video Conferencing. Key dates include a record date for final dividend on July 30, 2026, and remote e-voting from August 9 to August 11, 2026. Shareholders can access the report and notice on the company's website, stock exchange websites (BSE, NSE), and NSDL. Physical copies can be requested via email or through the Registrar and Transfer Agent (RTA).